| 1 | Neuroectodermal Tumors | 35.1% |
| 2 | Neoplasms, Neuroepithelial | 32.2% |
| 3 | Gliomatosis cerebri | 32.2% |
| 4 | Medulloblastoma | 30.9% |
| 5 | Chordoma | 28.8% |
| 6 | Teratoma | 28.8% |
| 7 | Germinoma | 28.8% |
| 8 | Teratocarcinoma | 28.8% |
| 9 | melanoma | 28.7% |
| 10 | Dermoid Cyst | 27.2% |
| 11 | Craniopharyngioma | 26.7% |
| 12 | Neuroectodermal Tumor, Melanotic | 26.7% |
| 13 | Neuroendocrine Tumors | 26.7% |
| 14 | Adenoma, Acidophil | 26.4% |
| 15 | Ganglioneuroma | 26.4% |
| 16 | Glioma | 26.4% |
| 17 | Malignant Glioma | 26.4% |
| 18 | Carcinoid Tumor | 25.2% |
| 19 | Neurilemmoma | 25.2% |
| 20 | Hutchinson's Melanotic Freckle | 24.7% |
| 21 | Melanoma, Amelanotic | 24.7% |
| 22 | Melanoma, Experimental | 24.4% |
| 23 | Astrocytoma | 23.5% |
| 24 | Ependymoma | 23.5% |
| 25 | oligodendroglioma | 23.5% |
| 26 | Ganglioglioma | 23.5% |
| 27 | gliosarcoma | 23.5% |
| 28 | Anaplastic astrocytoma | 23.5% |
| 29 | Anaplastic Oligodendroglioma | 23.5% |
| 30 | Malignant Carcinoid Syndrome | 22.9% |
| 31 | Paraganglioma | 22.5% |
| 32 | leukemia | 22.4% |
| 33 | Neoplasms, Glandular and Epithelial | 22.4% |
| 34 | Carcinoma 256, Walker | 22.4% |
| 35 | Glioblastoma | 22.1% |
| 36 | Neuroblastoma | 22.1% |
| 37 | Glioblastoma Multiforme | 22.1% |
| 38 | Dysgerminoma | 21.8% |
| 39 | Seminoma | 21.8% |
| 40 | Carcinosarcoma | 21.5% |
| 41 | Hemangiosarcoma | 21.5% |
| 42 | lymphangiosarcoma | 21.5% |
| 43 | Ganglioneuroblastoma | 21.4% |
| 44 | Pheochromocytoma | 20.5% |
| 45 | Meningioma | 20.4% |
| 46 | Hamartoma | 19.6% |
| 47 | Neoplasms, Hormone-Dependent | 19.6% |
| 48 | Neoplasms, Multiple Primary | 19.6% |
| 49 | Paraneoplastic Syndromes | 19.6% |
| 50 | Precancerous Conditions | 19.6% |
| 51 | Neoplasms, Second Primary | 19.6% |
| 52 | Carcinoma, Ehrlich Tumor | 19% |
| 53 | Carcinoma, Lewis Lung | 19% |
| 54 | Carcinoid Heart Disease | 18.9% |
| 55 | Basal cell carcinoma | 18.7% |
| 56 | Carcinoma, Papillary | 18.7% |
| 57 | Squamous cell carcinoma | 18.7% |
| 58 | Chondrosarcoma | 18.7% |
| 59 | Cystadenoma | 18.7% |
| 60 | leiomyosarcoma | 18.7% |
| 61 | liposarcoma | 18.7% |
| 62 | Mesothelioma | 18.7% |
| 63 | synovial sarcoma | 18.7% |
| 64 | Angiomyolipoma | 18.7% |
| 65 | Clear Cell Sarcoma of Soft Tissue | 18.7% |
| 66 | Alveolar Soft Part Sarcoma | 18.7% |
| 67 | Sarcoma, Myeloid | 18.7% |
| 68 | Carcinoma, Basal Cell | 18.7% |
| 69 | Retinoblastoma | 18.6% |
| 70 | Leukemia, Experimental | 18.1% |
| 71 | Histiocytic Disorders, Malignant | 17.8% |
| 72 | Leukemia, Plasma Cell | 17.8% |
| 73 | Cystadenocarcinoma | 17.3% |
| 74 | Fibrosarcoma | 17.3% |
| 75 | Osteosarcoma | 17.3% |
| 76 | Mucoepidermoid Carcinoma | 17.3% |
| 77 | Composite Lymphoma | 17.1% |
| 78 | Carcinoma, Lobular | 17% |
| 79 | Adenofibroma | 16.6% |
| 80 | Fibroadenoma | 16.6% |
| 81 | Malignant Fibrous Histiocytoma | 16.6% |
| 82 | Multiple Endocrine Neoplasia | 16.4% |
| 83 | Abruptio Placentae | 16.2% |
| 84 | Placenta Accreta | 16.2% |
| 85 | Leukemia L1210 | 16.1% |
| 86 | Leukemia P388 | 16.1% |
| 87 | Acanthoma | 16.1% |
| 88 | Endometrial Stromal Sarcoma | 16.1% |
| 89 | Chorioamnionitis | 15.9% |
| 90 | Bowen's Disease | 15.9% |
| 91 | Rhabdomyosarcoma | 15.9% |
| 92 | Giant Cell Tumor of Bone | 15.9% |
| 93 | Sarcoma, Experimental | 15.7% |
| 94 | Cyst | 15.7% |
| 95 | Neoplastic Processes | 15.7% |
| 96 | Neoplastic Syndromes, Hereditary | 15.7% |
| 97 | Acoustic Neuroma | 15.6% |
| 98 | Leukemia, Radiation-Induced | 15.6% |
| 99 | Polyhydramnios | 15.5% |
| 100 | Obstetric Labor Complications | 15.5% |
| 101 | Ectopic Pregnancy | 15.5% |
| 102 | Pregnancy, Prolonged | 15.5% |
| 103 | Puerperal Disorders | 15.5% |
| 104 | Oligohydramnios | 15.5% |
| 105 | Prenatal Injuries | 15.5% |
| 106 | Neoplasms, Experimental | 15.5% |
| 107 | Adenoma | 15.3% |
| 108 | Ameloblastoma | 15.3% |
| 109 | Angiokeratoma | 15.3% |
| 110 | Carcinoma | 15.3% |
| 111 | Hemangioma | 15.3% |
| 112 | hemangiopericytoma | 15.3% |
| 113 | Lymphangioma | 15.3% |
| 114 | Mesenchymoma | 15.3% |
| 115 | Nevus | 15.3% |
| 116 | Hepatoblastoma | 15.3% |
| 117 | Mixed Tumor, Mullerian | 15.3% |
| 118 | Angiofibroma | 15.3% |
| 119 | Sarcoma | 15.3% |
| 120 | Epithelioma | 15.3% |
| 121 | Dermatofibrosarcoma | 15.2% |
| 122 | Dermatofibrosarcoma Protuberans | 15.2% |
| 123 | Lymphoma | 14.8% |
| 124 | Sarcoma 180 | 14.7% |
| 125 | Vipoma | 14.6% |
| 126 | Thymoma | 14.5% |
| 127 | Alveolar rhabdomyosarcoma | 14.5% |
| 128 | Neurofibrosarcoma | 14.2% |
| 129 | Optic Nerve Glioma | 14.1% |
| 130 | Paraneoplastic Encephalomyelitis | 13.8% |
| 131 | Mammary Neoplasms, Experimental | 13.6% |
| 132 | Puerperal Infection | 13.5% |
| 133 | Postpartum Hemorrhage | 13.4% |
| 134 | Nephroblastoma | 13.2% |
| 135 | Lymphangioleiomyomatosis | 13.2% |
| 136 | Neoplasms, Radiation-Induced | 12.9% |
| 137 | Carcinoma, Pancreatic Ductal | 12.9% |
| 138 | Fetal Diseases | 12.9% |
| 139 | Pregnancy Complications, Cardiovascular | 12.9% |
| 140 | Pregnancy Complications, Hematologic | 12.5% |
| 141 | Pregnancy Complications, Infectious | 12.5% |
| 142 | Basal Cell Nevus Syndrome | 12.4% |
| 143 | Fetal Death | 12.3% |
| 144 | Perinatal death | 12.3% |
| 145 | Lymphomatoid Granulomatosis | 12.3% |
| 146 | Morning Sickness | 12.2% |
| 147 | Plasmacytoma | 12.2% |
| 148 | Malignant histiocytosis | 12.1% |
| 149 | Histiocytic sarcoma | 12.1% |
| 150 | Abdominal Neoplasms | 12.1% |
| 151 | Erythroplasia | 12.1% |
| 152 | Follicular cyst | 12.1% |
| 153 | Head and Neck Neoplasms | 12.1% |
| 154 | Mucocele | 12.1% |
| 155 | Pilonidal Cyst | 12.1% |
| 156 | Soft Tissue Neoplasms | 12.1% |
| 157 | Thoracic Neoplasms | 12.1% |
| 158 | Thyroglossal Cyst | 12.1% |
| 159 | Synovial Cyst | 12.1% |
| 160 | Aberrant Crypt Foci | 12.1% |
| 161 | Tuberous Sclerosis | 11.9% |
| 162 | Adenocarcinoma | 11.8% |
| 163 | Carcinoma in Situ | 11.8% |
| 164 | Carcinoma, Transitional Cell | 11.8% |
| 165 | Phyllodes Tumor | 11.8% |
| 166 | Hemangioendothelioma | 11.8% |
| 167 | Lipoma | 11.8% |
| 168 | Myoma | 11.8% |
| 169 | Myxoma | 11.8% |
| 170 | Neuroma | 11.8% |
| 171 | Papilloma | 11.8% |
| 172 | Pseudomyxoma Peritonei | 11.8% |
| 173 | Papillomatosis | 11.8% |
| 174 | Angiolipoma | 11.8% |
| 175 | Myelolipoma | 11.8% |
| 176 | Neoplasms, Bone Tissue | 11.8% |
| 177 | Neoplasms, Fibrous Tissue | 11.8% |
| 178 | Smooth Muscle Tumor | 11.8% |
| 179 | Adenomatosis, Pulmonary | 11.8% |
| 180 | Adenomatous Polyps | 11.8% |
| 181 | Carcinoma, Large Cell | 11.8% |
| 182 | Carcinoma, Small Cell | 11.8% |
| 183 | Desmoplastic Small Round Cell Tumor | 11.8% |
| 184 | Chondroma | 11.8% |
| 185 | Enchondroma | 11.8% |
| 186 | Multiple Endocrine Neoplasia Type 1 | 11.7% |
| 187 | Mesoblastic Nephroma | 10.9% |
| 188 | Hepatocellular Adenoma | 10.5% |
| 189 | Gestational Diabetes | 10.3% |
| 190 | Abortion, Habitual | 10.2% |
| 191 | Dystocia | 10.2% |
| 192 | Eclampsia | 10.2% |
| 193 | Fetal Membranes, Premature Rupture | 10.2% |
| 194 | Placental Insufficiency | 10.2% |
| 195 | Pre-Eclampsia | 10.2% |
| 196 | Prenatal Exposure Delayed Effects | 10.2% |
| 197 | HELLP Syndrome | 10.2% |
| 198 | Placenta, Retained | 10.2% |
| 199 | Uterine Inversion | 10.1% |
| 200 | Adenoid Cystic Carcinoma | 10% |
| 201 | fibroma | 10% |
| 202 | Fibromatosis | 10% |
| 203 | Osteoblastoma | 10% |
| 204 | Osteoma | 10% |
| 205 | Rhabdomyoma | 10% |
| 206 | Chondromatosis | 10% |
| 207 | Adenocarcinoma, Clear Cell | 10% |
| 208 | Cholangiocarcinoma | 10% |
| 209 | Cervical Intraepithelial Neoplasia | 10% |
| 210 | Hemangioblastoma | 10% |
| 211 | Lymphoma, Extranodal NK-T-Cell | 10% |
| 212 | Digestive System Neoplasms | 10% |
| 213 | Endocrine Gland Neoplasms | 10% |
| 214 | Eye Neoplasms | 10% |
| 215 | Hodgkin Disease | 10% |
| 216 | Lymphoma, Non-Hodgkin | 10% |
| 217 | Nervous System Neoplasms | 10% |
| 218 | Choriocarcinoma | 9.9% |
| 219 | Parathyroid Neoplasms | 9.8% |
| 220 | Peritoneal Neoplasms | 9.8% |
| 221 | Thyroid Neoplasm | 9.8% |
| 222 | Thyroid carcinoma | 9.8% |
| 223 | granulosa cell tumor | 9.8% |
| 224 | Carcinoma, Ovarian Epithelial | 9.8% |
| 225 | Bone neoplasms | 9.7% |
| 226 | Leukoplakia | 9.7% |
| 227 | Lymphocele | 9.7% |
| 228 | Pancreatic Cyst | 9.7% |
| 229 | Skin Neoplasms | 9.7% |
| 230 | Hematologic Neoplasms | 9.7% |
| 231 | Barrett Esophagus | 9.6% |
| 232 | Breast Cyst | 9.6% |
| 233 | Actinic keratosis | 9.6% |
| 234 | Mediastinal Cyst | 9.6% |
| 235 | Neoplasm Invasiveness | 9.6% |
| 236 | Neoplasm Metastasis | 9.6% |
| 237 | Neoplasm Recurrence, Local | 9.6% |
| 238 | Parovarian Cyst | 9.6% |
| 239 | Pericardial Cyst | 9.6% |
| 240 | Splenic Neoplasms | 9.6% |
| 241 | Thymic Cyst | 9.6% |
| 242 | Carcinogenesis | 9.6% |
| 243 | Myxoid cyst | 9.6% |
| 244 | Metastasis | 9.6% |
| 245 | Genital Neoplasms, Female | 9.5% |
| 246 | insulinoma | 9.4% |
| 247 | Leukemia, Myelomonocytic, Chronic | 9.3% |
| 248 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 9.3% |
| 249 | Corpus Luteum Cyst | 9.3% |
| 250 | Ovarian Cysts | 9.3% |
| 251 | Liver Neoplasms, Experimental | 9.2% |
| 252 | Carcinoma, Endometrioid | 9.2% |
| 253 | Fibromatosis, Aggressive | 9.2% |
| 254 | Fibromatosis, Abdominal | 9.2% |
| 255 | Klatskin Tumor | 9.2% |
| 256 | Prolactinoma | 9.1% |
| 257 | Growth Hormone-Secreting Pituitary Adenoma | 9.1% |
| 258 | Gastrinoma | 9.1% |
| 259 | Glucagonoma | 9.1% |
| 260 | Female Urogenital Diseases | 8.9% |
| 261 | Adenomatous Polyposis Coli | 8.9% |
| 262 | Tracheal Neoplasms | 8.8% |
| 263 | Renal Cell Carcinoma | 8.7% |
| 264 | Papillary Renal Cell Carcinoma | 8.7% |
| 265 | Pancreatic Neoplasm | 8.6% |
| 266 | Leukoplakia, Oral | 8.6% |
| 267 | Primary amyloidosis | 8.6% |
| 268 | Paraneoplastic Cerebellar Degeneration | 8.6% |
| 269 | Retroperitoneal Neoplasms | 8.5% |
| 270 | Uterine Rupture | 8.5% |
| 271 | Abortion, Veterinary | 8.5% |
| 272 | Pregnancy Complications, Parasitic | 8.5% |
| 273 | Leydig Cell Tumor | 8.3% |
| 274 | Lactation Disorder | 8.1% |
| 275 | Mastitis | 8.1% |
| 276 | Depression, Postpartum | 8.1% |
| 277 | Embryo Loss | 8.1% |
| 278 | Denys-Drash Syndrome | 8.1% |
| 279 | Fetal Resorption | 8.1% |
| 280 | Hyperemesis Gravidarum | 8% |
| 281 | Mastocytoma | 8% |
| 282 | Mastocytosis, Systemic | 8% |
| 283 | Urologic Neoplasms | 8% |
| 284 | Leukemia, Myeloid, Chronic-Phase | 7.9% |
| 285 | Mastocytosis | 7.9% |
| 286 | Sturge-Weber Syndrome | 7.9% |
| 287 | Gastrointestinal Stromal Tumors | 7.8% |
| 288 | Adrenocortical carcinoma | 7.8% |
| 289 | Hemangioma, Cavernous | 7.8% |
| 290 | Leukemia, T-Cell | 7.7% |
| 291 | Uterine Neoplasms | 7.7% |
| 292 | Vaginal Neoplasms | 7.7% |
| 293 | Vulvar Neoplasms | 7.7% |
| 294 | Uterine Cancer | 7.7% |
| 295 | Leukemia, B-Cell | 7.7% |
| 296 | neurofibroma | 7.7% |
| 297 | Lymphoma, Follicular | 7.7% |
| 298 | T-Cell Lymphoma | 7.7% |
| 299 | Mantle cell lymphoma | 7.7% |
| 300 | Uterine Cervical Incompetence | 7.6% |
| 301 | Thyroid Nodule | 7.6% |
| 302 | Premature Birth | 7.6% |
| 303 | Esophageal Neoplasms | 7.5% |
| 304 | Limbic Encephalitis | 7.5% |
| 305 | Fallopian Tube Neoplasms | 7.4% |
| 306 | Pregnancy Complications, Neoplastic | 7.1% |
| 307 | Neoplasms, Germ Cell and Embryonal | 6.9% |
| 308 | Germ Cell Cancer | 6.9% |
| 309 | Choledochal Cyst | 6.9% |
| 310 | Mouth Neoplasms | 6.8% |
| 311 | Central Nervous System Neoplasms | 6.8% |
| 312 | Vascular Neoplasms | 6.8% |
| 313 | Thymus Neoplasms | 6.8% |
| 314 | Fetal Growth Retardation | 6.8% |
| 315 | Trophoblastic Neoplasms | 6.8% |
| 316 | Embolism, Amniotic Fluid | 6.8% |
| 317 | Fetal Hypoxia | 6.8% |
| 318 | Fetal Alcohol Spectrum Disorders | 6.8% |
| 319 | Polycystic Ovary Syndrome | 6.8% |
| 320 | Pancreatic Pseudocyst | 6.8% |
| 321 | Lambert-Eaton Myasthenic Syndrome | 6.7% |
| 322 | Testicular Neoplasms | 6.7% |
| 323 | Lymphatic Metastasis | 6.7% |
| 324 | Neoplasms, Unknown Primary | 6.7% |
| 325 | Leukemic Infiltration | 6.7% |
| 326 | Breast Neoplasms, Male | 6.7% |
| 327 | Neoplasm Micrometastasis | 6.7% |
| 328 | Triple Negative Breast Neoplasms | 6.7% |
| 329 | Peutz-Jeghers Syndrome | 6.7% |
| 330 | Nasopharyngeal carcinoma | 6.7% |
| 331 | Breech Presentation | 6.7% |
| 332 | Waldenstrom Macroglobulinemia | 6.7% |
| 333 | Multiple Myeloma | 6.7% |
| 334 | Stillbirth | 6.6% |
| 335 | Endometrial Neoplasms | 6.6% |
| 336 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 6.6% |
| 337 | Leukemia, Large Granular Lymphocytic | 6.6% |
| 338 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6.6% |
| 339 | Lymphoma, T-Cell, Cutaneous | 6.6% |
| 340 | Lymphoma, AIDS-Related | 6.6% |
| 341 | Enteropathy-Associated T-Cell Lymphoma | 6.6% |
| 342 | Primary Effusion Lymphoma | 6.6% |
| 343 | ovarian neoplasm | 6.5% |
| 344 | Dupuytren Contracture | 6.2% |
| 345 | Urticaria Pigmentosa | 6.1% |
| 346 | Opsoclonus-Myoclonus Syndrome | 6% |
| 347 | Galactorrhea | 6% |
| 348 | Mycosis Fungoides | 6% |
| 349 | Lymphomatoid Papulosis | 6% |
| 350 | Plasmablastic lymphoma | 6% |
| 351 | Bladder Neoplasm | 5.8% |
| 352 | Kidney Neoplasm | 5.8% |
| 353 | Ureteral Neoplasms | 5.8% |
| 354 | Urethral Neoplasms | 5.8% |
| 355 | Adrenal Gland Neoplasms | 5.7% |
| 356 | Gastrointestinal Neoplasms | 5.7% |
| 357 | Genital Neoplasms, Male | 5.7% |
| 358 | Liver neoplasms | 5.7% |
| 359 | Uveal Neoplasms | 5.7% |
| 360 | Sebaceous Gland Neoplasms | 5.6% |
| 361 | Spinal Neoplasms | 5.6% |
| 362 | Bone Marrow Neoplasms | 5.6% |
| 363 | Palatal Neoplasms | 5.5% |
| 364 | Nose Neoplasms | 5.5% |
| 365 | Myelitis, Transverse | 5.4% |
| 366 | Meningeal Neoplasms | 5.4% |
| 367 | Meconium Aspiration Syndrome | 5.2% |
| 368 | Burkitt Lymphoma | 4.9% |
| 369 | Pituitary Adenoma | 4.9% |
| 370 | Pituitary Neoplasms | 4.9% |
| 371 | Meningeal Carcinomatosis | 4.7% |
| 372 | Ear Neoplasms | 4.6% |
| 373 | Eyelid Neoplasms | 4.6% |
| 374 | Lung Neoplasms | 4.6% |
| 375 | Pleural Neoplasms | 4.6% |
| 376 | Sezary Syndrome | 4.5% |
| 377 | Cell Transformation, Viral | 4.5% |
| 378 | Brain Neoplasms | 4.5% |
| 379 | Salivary Gland Neoplasms | 4.5% |
| 380 | Spinal Cord Neoplasms | 4.5% |
| 381 | Tongue Neoplasms | 4.5% |
| 382 | Xeroderma Pigmentosum | 4.3% |
| 383 | Urologic Diseases | 4.3% |
| 384 | Hydatidiform Mole | 4.1% |
| 385 | Bronchial Neoplasms | 3.9% |
| 386 | Pharyngeal Neoplasms | 3.9% |
| 387 | Multiple Pulmonary Nodules | 3.9% |
| 388 | Central Nervous System Cysts | 3.9% |
| 389 | Supratentorial Neoplasms | 3.9% |
| 390 | Bile Duct Neoplasms | 3.8% |
| 391 | gallbladder neoplasm | 3.8% |
| 392 | Intestinal Neoplasms | 3.8% |
| 393 | Penile Neoplasms | 3.8% |
| 394 | Prostatic Neoplasms | 3.8% |
| 395 | Stomach Neoplasms | 3.8% |
| 396 | Polycythemia Vera | 3.8% |
| 397 | Endometritis | 3.7% |
| 398 | Urogenital Abnormalities | 3.6% |
| 399 | Brain Stem Neoplasms | 3.6% |
| 400 | Laryngeal neoplasm | 3.5% |
| 401 | Choroid Plexus Papilloma | 3.4% |
| 402 | Endometriosis | 3.4% |
| 403 | Uterine Diseases | 3.4% |
| 404 | Vaginal Diseases | 3.4% |
| 405 | Vulvar Diseases | 3.4% |
| 406 | Endometrioma | 3.4% |
| 407 | Hypopharyngeal Neoplasms | 3.3% |
| 408 | Pleural Effusion, Malignant | 3.3% |
| 409 | Hypopharyngeal Cancer | 3.3% |
| 410 | Zollinger-Ellison syndrome | 3.3% |
| 411 | Salpingitis | 3.3% |
| 412 | Vulvovaginitis | 3.3% |
| 413 | Parotid Neoplasms | 3.3% |
| 414 | Prostatic Neoplasms, Castration-Resistant | 3.3% |
| 415 | Nelson Syndrome | 3.3% |
| 416 | Vesicovaginal Fistula | 3.1% |
| 417 | Tonsillar Neoplasms | 3.1% |
| 418 | Cerebellar Neoplasms | 3% |
| 419 | Hydrops Fetalis | 3% |
| 420 | Bladder Exstrophy | 3% |
| 421 | Epispadias | 3% |
| 422 | Tuberculosis, Renal | 2.9% |
| 423 | Cecal Neoplasms | 2.9% |
| 424 | Duodenal Neoplasms | 2.9% |
| 425 | Anuria | 2.9% |
| 426 | Ureterolithiasis | 2.9% |
| 427 | Nephrolithiasis | 2.9% |
| 428 | Oophoritis | 2.8% |
| 429 | Urinary Bladder Diseases | 2.7% |
| 430 | Infertility | 2.7% |
| 431 | Kidney Diseases | 2.7% |
| 432 | Ureteral Diseases | 2.7% |
| 433 | Urethral Diseases | 2.7% |
| 434 | Urination Disorders | 2.7% |
| 435 | Urolithiasis | 2.7% |
| 436 | Multicystic Dysplastic Kidney | 2.7% |
| 437 | Radicular Cyst | 2.7% |
| 438 | Appendiceal Neoplasms | 2.6% |
| 439 | Colonic Neoplasms | 2.6% |
| 440 | Rectal Neoplasms | 2.6% |
| 441 | Bladder neck obstruction | 2.6% |
| 442 | Nasopharyngeal Neoplasms | 2.6% |
| 443 | Colorectal Neoplasms | 2.6% |
| 444 | Endometrial Hyperplasia | 2.5% |
| 445 | Pyometra | 2.5% |
| 446 | Vaginitis | 2.5% |
| 447 | Vulvitis | 2.5% |
| 448 | Vaginal Discharge | 2.5% |
| 449 | Vulvodynia | 2.5% |
| 450 | Urinary Bladder Fistula | 2.5% |
| 451 | Candidiasis, Vulvovaginal | 2.5% |
| 452 | Kidney Calculi | 2.4% |
| 453 | Ureteral Calculi | 2.4% |
| 454 | Paranasal Sinus Neoplasms | 2.3% |
| 455 | Urinary tract infection | 2.3% |
| 456 | Horseshoe Kidney | 2.3% |
| 457 | Anus Neoplasms | 2.2% |
| 458 | Sigmoid Neoplasms | 2.2% |
| 459 | Pyelocystitis | 2.2% |
| 460 | Maxillary Sinus Neoplasms | 2.1% |
| 461 | Pyelonephritis | 2.1% |
| 462 | Uterine Cervicitis | 2.1% |
| 463 | Leukorrhea | 2.1% |
| 464 | Parametritis | 2.1% |
| 465 | Ovarian Diseases | 2% |
| 466 | Sexually Transmitted Diseases | 2% |
| 467 | Adnexitis | 2% |
| 468 | Cystitis | 2% |
| 469 | Hydronephrosis | 2% |
| 470 | Hyperoxaluria | 2% |
| 471 | Kidney Cortex Necrosis | 2% |
| 472 | Kidney Papillary Necrosis | 2% |
| 473 | Nephritis | 2% |
| 474 | Nephrosclerosis | 2% |
| 475 | Nephrosis | 2% |
| 476 | Perinephritis | 2% |
| 477 | Pruritus Vulvae | 2% |
| 478 | Kidney Failure | 2% |
| 479 | Uremia | 2% |
| 480 | Ureteral obstruction | 2% |
| 481 | Ureterocele | 2% |
| 482 | Urethral Obstruction | 2% |
| 483 | Urethritis | 2% |
| 484 | Uterine hemorrhage | 2% |
| 485 | Vaginal Fistula | 2% |
| 486 | Vesico-Ureteral Reflux | 2% |
| 487 | Urinary Retention | 2% |
| 488 | Pelvic Inflammatory Disease | 2% |
| 489 | Oxalosis | 2% |
| 490 | Renal Insufficiency | 2% |
| 491 | Uterine Prolapse | 2% |
| 492 | Vaginal Prolapse | 2% |
| 493 | Hermaphroditism | 2% |
| 494 | Disorders of Sex Development | 2% |
| 495 | Hypospadias | 1.9% |
| 496 | Genital Herpes | 1.9% |
| 497 | Diabetes Insipidus | 1.7% |
| 498 | Hepatorenal Syndrome | 1.7% |
| 499 | Bacterial Vaginosis | 1.7% |
| 500 | Dyspareunia | 1.7% |
| 501 | Bacteriuria | 1.7% |
| 502 | Diabetic Nephropathy | 1.7% |
| 503 | Glycosuria | 1.7% |
| 504 | Hematuria | 1.7% |
| 505 | Renal hypertension | 1.7% |
| 506 | Oliguria | 1.7% |
| 507 | Polyuria | 1.7% |
| 508 | Proteinuria | 1.7% |
| 509 | Pyuria | 1.7% |
| 510 | Renal Artery Obstruction | 1.7% |
| 511 | Renal Artery Stenosis | 1.7% |
| 512 | Urinary Calculi | 1.7% |
| 513 | Trichomonas Vaginitis | 1.7% |
| 514 | Uterine Perforation | 1.7% |
| 515 | Ovarian Hyperstimulation Syndrome | 1.7% |
| 516 | Cystocele | 1.7% |
| 517 | Nephrocalcinosis | 1.7% |
| 518 | Urinary Incontinence | 1.7% |
| 519 | Glomerulonephritis | 1.7% |
| 520 | Metrorrhagia | 1.7% |
| 521 | Nephritis, Interstitial | 1.7% |
| 522 | Lipoid nephrosis | 1.7% |
| 523 | Nephrotic Syndrome | 1.7% |
| 524 | Pyelitis | 1.7% |
| 525 | Pyonephrosis | 1.7% |
| 526 | Urethral Stenosis | 1.7% |
| 527 | Nephrogenic Diabetes Insipidus | 1.7% |
| 528 | Congenital Nephrogenic Diabetes Insipidus | 1.7% |
| 529 | Acute kidney injury | 1.7% |
| 530 | Urethral stricture | 1.7% |
| 531 | Glycosuria, Renal | 1.6% |
| 532 | Balkan Nephropathy | 1.5% |
| 533 | Focal glomerulosclerosis | 1.5% |
| 534 | Kidney Failure, Chronic | 1.5% |
| 535 | Hyperandrogenism | 1.5% |
| 536 | Enuresis | 1.4% |
| 537 | Gonadal Dysgenesis | 1.4% |
| 538 | Adrenogenital Syndrome | 1.4% |
| 539 | Ovotesticular Disorders of Sex Development | 1.4% |
| 540 | Azotemia | 1.4% |
| 541 | Anovulation | 1.4% |
| 542 | Menorrhagia | 1.4% |
| 543 | Albuminuria | 1.4% |
| 544 | Hemoglobinuria | 1.4% |
| 545 | Hypertension, Renovascular | 1.4% |
| 546 | Premature Menopause | 1.4% |
| 547 | Urge Incontinence | 1.4% |
| 548 | Glomerulonephritis, Membranoproliferative | 1.3% |
| 549 | AIDS-Associated Nephropathy | 1.2% |
| 550 | Polycystic Kidney Diseases | 1.2% |
| 551 | Diurnal Enuresis | 1.2% |
| 552 | Renal Aminoacidurias | 1.2% |
| 553 | Fanconi Syndrome | 1.2% |
| 554 | Pseudohypoaldosteronism | 1.2% |
| 555 | Liddle Syndrome | 1.2% |
| 556 | Hemolytic-Uremic Syndrome | 1.2% |
| 557 | Anti-Glomerular Basement Membrane Disease | 1.1% |
| 558 | Lupus Nephritis | 1.1% |
| 559 | Polycystic Kidney, Autosomal Dominant | 1.1% |
| 560 | Cystinuria | 1.1% |
| 561 | Atypical Hemolytic Uremic Syndrome | 1% |
| 562 | Chlamydia Infections | 1% |
| 563 | Gonorrhea | 1% |
| 564 | Renal tubular acidosis | 1% |
| 565 | Turner Syndrome | 1% |
| 566 | Renal Osteodystrophy | 1% |
| 567 | Renal rickets | 1% |
| 568 | Kallmann Syndrome | 0.9% |
| 569 | Lymphogranuloma Venereum | 0.9% |
| 570 | Syphilis | 0.9% |
| 571 | Hyperphosphaturia | 0.8% |
| 572 | Klinefelter Syndrome | 0.8% |
| 573 | Zellweger Syndrome | 0.8% |
| 574 | Familial Hypophosphatemic Rickets | 0.5% |